Chemical Structure : Senexin A
CAS No.: 1366002-50-7
货号: PC-44628Not For Human Use, Lab Use Only.
Senexin A is a selective inhibitor of CDK8 (IC50=0.28 uM) and CDK19, inhibits CDK8 and CDK19 ATP site binding with Kd50 of 0.83 uM and 0.31 uM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥980 | In stock | |
10 mg | ¥1480 | In stock | |
25 mg | ¥2580 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Senexin A is a selective inhibitor of CDK8 (IC50=0.28 uM) and CDK19, inhibits CDK8 and CDK19 ATP site binding with Kd50 of 0.83 uM and 0.31 uM, respectively.
Senexin A inhibits only p21-induced transcription but not other biological effects of p21, inhibits β-catenin-dependent transcription in HCT116 colon carcinoma cells.
Senexin A suppresses damage-induced tumor-promoting paracrine activities of tumor cells and normal fibroblasts.
Senexin A reverses the increase in tumor engraftment and serum mitogenic activity in mice pretreated with doxorubicin.
分子量 | 274.32 | |
分子式 | C17H14N4 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥100 mg/mL |
|
Chemical Name/SMILES |
6-Quinazolinecarbonitrile, 4-[(2-phenylethyl)amino]- |
1. Porter DC, et al. Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13799-804.
2. McDermott MS, et al. Oncotarget. 2017 Feb 21;8(8):12558-12575.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright